James Schultz

Array ( [id] => 5598078 [patent_doc_number] => 20060161996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Process for producing human-origin immunocompetent cell' [patent_app_type] => utility [patent_app_number] => 10/560829 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10680 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20060161996.pdf [firstpage_image] =>[orig_patent_app_number] => 10560829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255761 [patent_doc_number] => 20040259767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Treatment of pml targeting jc virus agno' [patent_app_type] => new [patent_app_number] => 10/496391 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3086 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259767.pdf [firstpage_image] =>[orig_patent_app_number] => 10496391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4612119 [patent_doc_number] => 07988957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Gene introduction efficiency enhancer' [patent_app_type] => utility [patent_app_number] => 10/554246 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5070 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/988/07988957.pdf [firstpage_image] =>[orig_patent_app_number] => 10554246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7263893 [patent_doc_number] => 20040241845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Mammalian staufen and use thereof' [patent_app_type] => new [patent_app_number] => 10/820060 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 40183 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241845.pdf [firstpage_image] =>[orig_patent_app_number] => 10820060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288090 [patent_doc_number] => 20040147477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Antisense modulation of P70 S6 kinase expression' [patent_app_type] => new [patent_app_number] => 10/795662 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25691 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147477.pdf [firstpage_image] =>[orig_patent_app_number] => 10795662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733486 [patent_doc_number] => 20060258603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Transposon-based targeting system' [patent_app_type] => utility [patent_app_number] => 10/544971 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9471 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258603.pdf [firstpage_image] =>[orig_patent_app_number] => 10544971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4581527 [patent_doc_number] => 07851150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Detection of small nucleic acids' [patent_app_type] => utility [patent_app_number] => 10/740256 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22191 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851150.pdf [firstpage_image] =>[orig_patent_app_number] => 10740256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468129 [patent_doc_number] => 20040120970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Use of bacterium for manufacture of a vaccine' [patent_app_type] => new [patent_app_number] => 10/731724 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2865 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120970.pdf [firstpage_image] =>[orig_patent_app_number] => 10731724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466166 [patent_doc_number] => 20040101910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Human Thymosin, beta15 gene, protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/726422 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10102 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101910.pdf [firstpage_image] =>[orig_patent_app_number] => 10726422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4464468 [patent_doc_number] => 07935676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2A, and a cell having such nucleic acid construct introduced therein' [patent_app_type] => utility [patent_app_number] => 10/558155 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 16215 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935676.pdf [firstpage_image] =>[orig_patent_app_number] => 10558155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288077 [patent_doc_number] => 20040147472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Antisense modulation of transforming growth factor beta receptor II expression' [patent_app_type] => new [patent_app_number] => 10/705715 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27296 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147472.pdf [firstpage_image] =>[orig_patent_app_number] => 10705715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288076 [patent_doc_number] => 20040147471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Antisense modulation of TNFR1 expression' [patent_app_type] => new [patent_app_number] => 10/702817 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19768 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147471.pdf [firstpage_image] =>[orig_patent_app_number] => 10702817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7263887 [patent_doc_number] => 20040241843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Antisense modulation of interleukin 12 p40 subunit expression' [patent_app_type] => new [patent_app_number] => 10/476961 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25820 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241843.pdf [firstpage_image] =>[orig_patent_app_number] => 10476961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348645 [patent_doc_number] => 20040248297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Antisense modulation of phospholipase a2, group vi (ca2+independent) expression' [patent_app_type] => new [patent_app_number] => 10/476991 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25324 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248297.pdf [firstpage_image] =>[orig_patent_app_number] => 10476991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355101 [patent_doc_number] => 20040048825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => ' Antisense modulation of CREB expression' [patent_app_type] => new [patent_app_number] => 10/672981 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25763 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048825.pdf [firstpage_image] =>[orig_patent_app_number] => 10672981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736988 [patent_doc_number] => 07033830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Antisense modulation of MyD88 expression' [patent_app_type] => utility [patent_app_number] => 10/673063 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25618 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033830.pdf [firstpage_image] =>[orig_patent_app_number] => 10673063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906160 [patent_doc_number] => 20050101555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Antisense modulation of caspase 7 expression' [patent_app_type] => utility [patent_app_number] => 10/663451 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26182 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101555.pdf [firstpage_image] =>[orig_patent_app_number] => 10663451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7461863 [patent_doc_number] => 20040197906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Antisense modulation of PKA regulatory subunit RII beta expession' [patent_app_type] => new [patent_app_number] => 10/659473 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25375 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197906.pdf [firstpage_image] =>[orig_patent_app_number] => 10659473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468064 [patent_doc_number] => 20040198967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Compositions and methods for tissue specific or inducible inhibition of gene expression' [patent_app_type] => new [patent_app_number] => 10/655570 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15103 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198967.pdf [firstpage_image] =>[orig_patent_app_number] => 10655570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677174 [patent_doc_number] => 20040152652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Antisense Oligonucleotide modulation of tumor necrosis factor-alpha (TNF-alpha) expression' [patent_app_type] => new [patent_app_number] => 10/647918 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 37490 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152652.pdf [firstpage_image] =>[orig_patent_app_number] => 10647918 [rel_patent_id] =>[rel_patent_doc_number] =>)